| Patents for C07K 2 - Peptides of undefined number of amino acids; Derivatives thereof (4,723) |
|---|
| 02/03/2011 | US20110027829 Methods and Compositions |
| 02/03/2011 | US20110027800 Derivatives of 1,2-dihydro-7-hydroxyquinolines Containing Fused Rings |
| 02/03/2011 | US20110027293 Methods and compositions for the inhibition of viral infection by targeting intracellular trafficking |
| 02/03/2011 | US20110027277 Predictive marker for topoisomerase i inhibitors |
| 02/03/2011 | US20110027269 14-3-3 Antagonists for the Prevention and Treatment of Arthritis |
| 02/02/2011 | CN101962400A Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 01/27/2011 | US20110021745 Ultra-small chitosan nanoparticles useful as bioimaging agents and methods of making same |
| 01/27/2011 | US20110021546 Gene Defects And Mutant ALK Kinase In Human Solid Tumors |
| 01/27/2011 | US20110020868 Bacterial leader sequences for increased expression |
| 01/27/2011 | US20110020786 Peptide dendrimers: affinity reagents for binding noroviruses |
| 01/27/2011 | US20110020649 Method for immobilization, physiologically active substance-immobilized carrier, carrier for immobilization, carrier, and process for producing carrier |
| 01/27/2011 | US20110020402 Method For Identification, Isolation And Production Of Antigens To A Specific Pathogen |
| 01/27/2011 | US20110020390 Meningococcal fhbp polypeptides |
| 01/27/2011 | US20110020378 Self-assembling peptide nanoparticles useful as vaccines |
| 01/27/2011 | US20110020335 Treatment of Cancers Expressing p95 ErbB2 |
| 01/27/2011 | US20110020273 Bispecific Immunocytokine Dock-and-Lock (DNL) Complexes and Therapeutic Use Thereof |
| 01/27/2011 | US20110017599 Target recognition molecule and a method for immobilizing the same |
| 01/26/2011 | EP1303186B1 Medicinal uses of mu-opioid receptor agonists |
| 01/26/2011 | CN101240014B Lipopeptid composition with physiological activity and its preparation method and application |
| 01/20/2011 | US20110016579 Gene of transporter selective to mugineic acid-iron complex |
| 01/20/2011 | US20110016548 Control of endogenous dnmt1 gene expression by exogenous binary regulatory systems |
| 01/20/2011 | US20110015123 Modulation of GLUT4 Gene Promoter activity BY AHNAK |
| 01/20/2011 | US20110014599 Novel Fluorescent Dyes and Uses Thereof |
| 01/20/2011 | US20110014473 Polymer-coated nanoparticles |
| 01/20/2011 | US20110014210 Chlamydia vaccine |
| 01/20/2011 | US20110014185 Methods involving graf polypeptides |
| 01/20/2011 | US20110014128 Cytokine receptor modulators, method of identifying same, and method of modulating cytokine receptors activity with same |
| 01/20/2011 | US20110014120 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
| 01/19/2011 | EP1773867B1 Proteinaceous compounds and uses therefor |
| 01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
| 01/19/2011 | CN101951936A Methods for prevention and treatment of acute renal injury |
| 01/19/2011 | CN101352249B Production method for fully using oil-containing micro-algae |
| 01/19/2011 | CN101072791B S-alkyl-sulphenyl protection groups in solid-phase synthesis |
| 01/13/2011 | WO2011006069A1 Peptides for binding fibrinogen and fibrin |
| 01/13/2011 | US20110008357 Antibodies that bind il-18 and methods of inhibiting il-18 activity |
| 01/13/2011 | US20110008302 Compositions and methods for immortalizing cells and screening for anti-cancer agents |
| 01/13/2011 | US20110008212 Chemical sensor having sensitive film imitating olfactory receptor |
| 01/12/2011 | EP2271660A2 Stabilized liquid enzyme compositions |
| 01/06/2011 | WO2010121259A3 Protein matrix for light-initiated electron transfer |
| 01/06/2011 | US20110003711 Cell lines expressing gaba receptor and methods using them |
| 01/06/2011 | US20110003702 Methods, systems, and kits for identification of osteoinductive peptides |
| 01/06/2011 | US20110003314 Hapten, Immunogens and Derivatives of Ascomycin Useful for Preparation of Antibodies and Immunoassays |
| 01/06/2011 | US20110003313 Amplified labeled conjugate for use in immunoassays |
| 01/05/2011 | EP2269471A1 Method for production of defatted soymilk peptide |
| 01/05/2011 | EP2016950B1 Pharmaceutical composition comprising an exendin-4 peptide |
| 01/05/2011 | EP1301202B1 Genetically-engineered mhc molecules |
| 01/05/2011 | DE102009024720A1 Massenspektrometrischer Endopeptidasen-Assay Mass spectrometric assay endopeptidases |
| 01/05/2011 | CN101935634A Clonal strain of cabbage looper cell line and application thereof |
| 01/04/2011 | US7863058 solid phase synthesis of oligonucleotides and peptides on silicon chips, multiwell plates, glass beads |
| 01/04/2011 | CA2516661C M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 12/30/2010 | US20100331255 Compositions and Methods for Increasing Production of Recombinant Gamma-Carboxylated Proteins |
| 12/30/2010 | US20100331235 Histidine and/or Histidine Derivative for the Treatment of Inflammatory Skin Diseases |
| 12/30/2010 | US20100330697 Complexes of trpc domains and sestd1 domains and methods and uses involving the same |
| 12/30/2010 | US20100330680 Labeling peptides with tertiary amines and other basic functional groups for improved mass spectrometric analysis |
| 12/30/2010 | US20100330085 Method of treatment, prophylaxis and diagnosis of pathologies of the bone |
| 12/29/2010 | CN101928742A Whey protein active peptide with antioxidant activity and preparation method thereof |
| 12/29/2010 | CN101928719A T vector for screening solubility expression of protein and construction method and application thereof |
| 12/29/2010 | CN101927007A Method for imaging tumor tissue |
| 12/28/2010 | US7858679 Polymeric compositions and related methods of use |
| 12/23/2010 | WO2010147998A2 Quenched fluorophores conjugated to peptides via linkers containing dithio groups |
| 12/23/2010 | US20100324266 Photocleavable Protecting Groups |
| 12/23/2010 | US20100324215 Affinity structures for the specific binding of substances by means of non-covalent interaction types |
| 12/23/2010 | US20100324114 Methods and kits to detect hereditary angioedema type III |
| 12/23/2010 | US20100324008 Psma binding ligand-linker conjugates and methods for using |
| 12/23/2010 | US20100322977 Biomaterials, compositions, and methods |
| 12/23/2010 | US20100322959 Immunogenic composition |
| 12/23/2010 | US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using |
| 12/16/2010 | US20100319091 Methods of modulating production of phenylpropanoid compounds in plants |
| 12/16/2010 | US20100319086 Leafy cotyledon 1 transcriptional activator (lec1) variant polynucleotides and polypeptides, compositions and methods of increasing oil content in plants |
| 12/16/2010 | US20100317832 Aziridine aldehydes, aziridine-conjugated amino derivatives, aziridine-conjugated biomolecules and processes for their preparation |
| 12/16/2010 | US20100317827 Method of Purifying a Peptide |
| 12/16/2010 | US20100317714 Complex molecule interfering the expression of target genes and its preparing methods |
| 12/16/2010 | US20100317563 Methods for modulating the proliferation and differentiation potential of stem cells and progenitor cells |
| 12/16/2010 | US20100317547 Methods and compositions |
| 12/16/2010 | US20100317026 VMP-Like Sequences Of Pathogenic Borrelia |
| 12/16/2010 | US20100317024 Derivatives, reagents, and immunoassay for detecting levetiracetam |
| 12/16/2010 | US20100316993 Method for enriching a prokaryotic dna |
| 12/16/2010 | US20100316631 Water Soluble Curcumin-Based Compounds |
| 12/16/2010 | US20100316574 Oncofetal Antigen/Immature Laminin Receptor Peptides for the Sensitization of Dendritic Cells for Cancer Therapy |
| 12/15/2010 | CN101914134A Linear epitope minimum motif peptide of human papilloma virus type 58 E7 protein |
| 12/15/2010 | CN101914093A Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates |
| 12/14/2010 | US7851618 Aminated complex-type sugar chain derivatives and process for the production thereof |
| 12/09/2010 | US20100311641 Peptide-based body surface coloring reagents |
| 12/09/2010 | US20100311640 Self-assembling peptide incorporating modifications and methods of use thereof |
| 12/09/2010 | US20100310877 Protein-Containing Emulsions and Adhesives, and Manufacture and Use Thereof |
| 12/09/2010 | US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 12/09/2010 | US20100310579 Method for inhibiting angiogenesis or for treatment of cancer |
| 12/09/2010 | US20100310576 COMPOSITIONS AND METHODS COMPRISING ASPARTYL-tRNA SYNTHETASES HAVING NON-CANONICAL BIOLOGICAL ACTIVITIES |
| 12/09/2010 | US20100310510 N-terminally chemically modified protein compositions and methods |
| 12/08/2010 | CN101906451A Phanerochaete chrysosporium ecto polymer and extraction method and application thereof |
| 12/08/2010 | CN101531700B Maize oligopeptide preparing method |
| 12/02/2010 | US20100305626 Adhesive complex coacervates and methods of making and using thereof |
| 12/02/2010 | US20100305227 Protein-Containing Foams, Manufacture and Use Thereof |
| 12/02/2010 | US20100304497 Fluorescent protein and chromoprotein |
| 12/02/2010 | US20100303866 Immunogenic peptides and their use in immune disorders |
| 12/02/2010 | US20100303835 Peptoid ligands for isolation and treatment of autoimmune t-cells |
| 12/02/2010 | US20100303754 Process for preparation of cyclodextrin oligomers or polymers, products obtained and uses |
| 11/25/2010 | US20100298529 Manufacture and use of modified polysaccharide chitosan bonds and a process to improve the preparation of hes-medicinal substance compounds |
| 11/25/2010 | US20100298167 Novel cell lines expressing enac and methods using them |
| 11/25/2010 | US20100297777 Sub-diffraction limit image resolution and other imaging techniques |